Does vascepa's effectiveness change when taken with probiotics?

Does combining Vascepa with probiotics affect how well it works?

Vascepa is a prescription form of purified eicosapentaenoic acid (EPA) that reduces triglyceride levels and lowers cardiovascular risk in certain patients. Probiotics are live bacteria taken to support gut health. No clinical studies have examined whether probiotics directly alter Vascepa’s lipid-lowering effects or cardiovascular benefits.

How does Vascepa get absorbed and does gut bacteria influence it?

Vascepa is absorbed primarily in the small intestine. EPA is already in its ethyl ester form, which requires pancreatic enzymes to convert it into a fatty acid that can be incorporated into plasma. Gut bacteria do not play a significant role in this process. Current evidence shows that probiotics do not materially change EPA levels in the blood or interfere with Vascepa’s reported efficacy.

What happens if a patient takes both products together?

Patients who take Vascepa and probiotics on the same day receive the benefits of each without documented interference. Many people use probiotics after taking broad-spectrum antibiotics, and some cardiovascular patients also need these products. No adverse interactions appear in prescribing information or clinical reports.

Why are companies challenging this patent?

Amarin’s core composition-of-matter patent for Vascepa expires in 2030. Several generic manufacturers filed Abbreviated New Drug Applications (ANDAs) and Paragraph IV challenges claiming the company’s manufacturing process and patent claims are invalid or non-patentable. The challenges center on whether the 96% pure EPA ethyl ester is obvious given existing omega-3 products.